Delivery Order SPE2DR25D3012-SPE2DR26F4C7S
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,133.31 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on November 20, 2025, with an ultimate completion date of November 21, 2025. This firm fixed price, competitively awarded contract (no set-aside) is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $39,449.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on November 25, 2025, with completion expected by November 26, 2025. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,824.82 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on June 16, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of June 17, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $5,964.68 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on December 2, 2025, with completion scheduled for December 3, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive...
- The Defense Logistics Agency has awarded a delivery order valued at $1,691.15 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens. The order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $8,764.26. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 22, 2025, and performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $1,380.90 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 26, 2025, with completion expected by August 27, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and specifies performance at the vendor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $3,169.20 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on December 5, 2025, with completion scheduled for December 8, 2025. This non-competitive delivery order utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated...
- The Defense Logistics Agency awarded a delivery order valued at $1,744.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL) on December 4, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,228.91 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price delivery order represents a non-competitive set-aside transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4C7SDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,369.06 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on December 3, 2025, with a completion date of December 4, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a robust federal contract portfolio with the Defense Logistics Agency, supplying a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The parent IDC vehicle enables the company to deliver diverse medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Trulicity, a diabetes medication, exemplifies the company's role as a critical vendor in the federal medical supply chain under DLA's Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 12/2/25 |